Foresight Diagnostics

aid: foresight-diagnostics
name: Foresight Diagnostics
description: 'Foresight Diagnostics is a CLIA-certified, CAP-accredited cancer diagnostics company founded in 2020 in Boulder,
  Colorado by Stanford physicians and scientists, and since February 2026 a wholly owned subsidiary of Natera. Its Foresight
  CLARITY minimal residual disease (MRD) platform is a liquid-biopsy test powered by proprietary PhasED-Seq phased-variant
  sequencing and bioinformatics, detecting circulating tumor DNA at an analytical sensitivity below one part per million across
  lymphoma, lung and other solid tumors. The company sells laboratory testing services to biopharma sponsors, academic researchers
  and clinicians rather than software: it operates a central laboratory and publishes no public developer program, API, SDK
  or machine-readable specification of any kind.'
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - rate-limits
  - security
  generated: '2026-09-02'
  method: derived
image: https://foresight-dx.com/wp-content/uploads/2024/09/X-OpenGraph-Image-1200x630-2x.png
url: https://raw.githubusercontent.com/api-evangelist/foresight-diagnostics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment-pass
specificationVersion: '0.23'
created: '2026-08-16'
modified: '2026-08-16'
tags:
- Company
- Healthcare
- Diagnostics
- Oncology
- Genomics
- Precision Medicine
- Laboratory
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://foresight-dx.com/
- type: Products
  url: https://foresight-dx.com/foresight-products-services/
- type: Technology
  url: https://foresight-dx.com/our-technology/
- type: Resources
  url: https://foresight-dx.com/resources/
- type: News
  url: https://foresight-dx.com/news/
- type: BlogRSS
  url: https://foresight-dx.com/feed/
- type: Support
  url: https://foresight-dx.com/contact/
- type: TermsOfService
  url: https://foresight-dx.com/terms-of-use/
- type: PrivacyPolicy
  url: https://foresight-dx.com/privacy-policy/
- type: Careers
  url: https://foresight-dx.com/careers/
- type: Compliance
  url: conformance/foresight-diagnostics-conformance.yml
- type: Conformance
  url: conformance/foresight-diagnostics-conformance.yml
- type: DomainSecurity
  url: security/foresight-diagnostics-domain-security.yml
- type: LLMsTxt
  url: llms/foresight-diagnostics-llms.txt
x-enrichment:
  date: '2026-08-16'
  status: minimal
  artifacts_added: 6
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: 'Foresight Diagnostics is a CLIA-certified central laboratory that sells a liquid-biopsy MRD test, not software:
    its entire public presence is a 20-page WordPress marketing site whose only machine-readable endpoint is the stock WordPress
    wp-json CMS API, and no api./portal./developer./docs./app./results./ provider./status. subdomain of foresight-dx.com resolves
    in DNS.'
  evidence:
  - url: https://foresight-dx.com/openapi.json
    status: 404
  - url: https://foresight-dx.com/graphql
    status: 404
  - url: https://foresight-dx.com/.well-known/agent-card.json
    status: 404
  - url: https://foresight-dx.com/llms.txt
    status: 404
  - url: https://foresight-dx.com/page-sitemap1.xml
    status: 200
  checked: '2026-08-16'